These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13826540)

  • 1. Monoamine oxidase inhibitors. I. 1-Alkyl and 1-aralkyl-2-(picolinoyl and 5-methyl-3-isoxazolyl-carbonyl)hydrazines.
    GARDNER TS; WENIS E; LEE J
    J Med Pharm Chem; 1960 Apr; 2():133-45. PubMed ID: 13826540
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
    HORITA A; McGRATH WR
    Proc Soc Exp Biol Med; 1960 Apr; 103():753-7. PubMed ID: 14403108
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors. II. Some amino and dialkylaminobenzyl hydrazines and their acyl derivatives.
    GARDNER TS; WENIS E; LEE J
    J Med Pharm Chem; 1961 Mar; 3():241-52. PubMed ID: 13896916
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A
    Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacological evaluation of monoamine oxidase inhibitors.
    LESSIN AW
    Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A
    Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticonvulsant properties of monoamine oxidase inhibitors.
    PROCKOP DJ; SHORE PA; BRODIE BB
    Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994
    [No Abstract]   [Full Text] [Related]  

  • 8. Amino acid and fatty acid hydrazides: chemistry and action on monoamine oxidase.
    ZELLER P; PLETSCHER A; GEY KF; GUTMANN H; HEGEDUS B; STRAUB O
    Ann N Y Acad Sci; 1959 Sep; 80():555-67. PubMed ID: 13847238
    [No Abstract]   [Full Text] [Related]  

  • 9. The THERAPEUTIC action of monoamine oxidase inhibitors.
    Angiology; 1960 Feb; 11():55-7. PubMed ID: 13856617
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors and angina pectoris.
    WINSOR T; ZARCO P
    Angiology; 1960 Feb; 11():67-75. PubMed ID: 13845298
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine oxidase inhibitors in the treatment of angina pectoris.
    RUSSEK HI
    Angiology; 1960 Feb; 11():76-80. PubMed ID: 14440277
    [No Abstract]   [Full Text] [Related]  

  • 12. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors and vascular disease.
    FISHBEIN M
    Angiology; 1960 Feb; 11():53-4. PubMed ID: 13823176
    [No Abstract]   [Full Text] [Related]  

  • 14. On the mechanism of action of monoamine oxidase inhibitors in angina pectoris.
    PLETSCHER A; GEY KF
    J Am Geriatr Soc; 1961 Jun; 9():410-8. PubMed ID: 13736338
    [No Abstract]   [Full Text] [Related]  

  • 15. Experiences in the treatment of angina pectoris with monoamine oxidase inhibitors.
    OBLATH RW; GRIFFITH GC
    J Am Geriatr Soc; 1961 Jun; 9():427-31. PubMed ID: 13730182
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical toxicity studies of a monoamine oxidase inhibitor.
    GREENBLATT IJ; KAHN A
    Ann N Y Acad Sci; 1959 Sep; 80():947-59. PubMed ID: 13851575
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of the monoamine oxidase inhibitors in cardiovascular disease.
    GRIFFITH GC
    Am J Cardiol; 1960 Dec; 6():1103-5. PubMed ID: 13708592
    [No Abstract]   [Full Text] [Related]  

  • 18. A non-hydrazine monoamine oxidase inhibitor with antihypertensive properties.
    HORWITZ D; SJOERDSMA A
    Proc Soc Exp Biol Med; 1961 Jan; 106():118-20. PubMed ID: 13716049
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
    [No Abstract]   [Full Text] [Related]  

  • 20. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.